BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10346681)

  • 1. Off-label promotion: is FDA's final guidance on industry-supported scientific and educational programs enforceable?
    Bass IS; Kalb PE; Berenson BA
    Food Drug Law J; 1998; 53(2):193-212. PubMed ID: 10346681
    [No Abstract]   [Full Text] [Related]  

  • 2. Marketing off-label uses to physicians: FDA's draft (mis)guidance.
    Gass A; Wilson J
    Am J Bioeth; 2008 Mar; 8(3):1-3. PubMed ID: 18570084
    [No Abstract]   [Full Text] [Related]  

  • 3. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM; Gross M
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract]   [Full Text] [Related]  

  • 4. Pitching doctors.
    Wilkes MS; Shuchman M
    N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 6. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P;
    Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
    [No Abstract]   [Full Text] [Related]  

  • 7. Criminalizing knowledge: the perverse implications of the intended use regulations of off-label promotion prosecutions.
    Gentry G
    Food Drug Law J; 2009; 64(3):441-58. PubMed ID: 19999637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplement labeling and advertising claims: are clinical studies on the full product required?
    Villafranco JE; Bond K
    Food Drug Law J; 2009; 64(1):43-67. PubMed ID: 19998572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The WLF case thus far: not with a bang, but a whimper.
    Cooper RM
    Food Drug Law J; 2000; 55(4):477-89. PubMed ID: 12025847
    [No Abstract]   [Full Text] [Related]  

  • 10. Surfing the Net in shallow waters: product liability concerns and advertising on the Internet.
    Moberg MA; Wood JW; Dorfman HL
    Food Drug Law J; 1998; 53(2):213-24. PubMed ID: 10346682
    [No Abstract]   [Full Text] [Related]  

  • 11. First Amendment limits on regulating information: an initial reaction to the Washington Legal Foundation case.
    Gibbs JN
    Food Drug Law J; 1998; 53(4):597-601. PubMed ID: 10557578
    [No Abstract]   [Full Text] [Related]  

  • 12. Academics face abuse of rules designed to protect research.
    Cowen RC
    Christ Sci Monitor; 1998 Mar; ():13. PubMed ID: 11647561
    [No Abstract]   [Full Text] [Related]  

  • 13. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM
    Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification and consumer information: modern biotechnology and the regulation of information.
    Beales JH
    Food Drug Law J; 2000; 55(1):105-17. PubMed ID: 12322718
    [No Abstract]   [Full Text] [Related]  

  • 16. Is FDA's medical device evaluation process overly complaisant to industry?
    Margolis RE
    Healthspan; 1992; 9(7):19-20. PubMed ID: 10121440
    [No Abstract]   [Full Text] [Related]  

  • 17. When researchers accept funding from the tobacco industry, do ethics go up in smoke?
    Wolinsky H
    N Y State J Med; 1985 Jul; 85(7):451-4. PubMed ID: 11643879
    [No Abstract]   [Full Text] [Related]  

  • 18. "It's time to make a good agency better": the Food and Drug Administration Modernization Act of 1997 and the First Amendment.
    Murphy AM
    Food Drug Law J; 1998; 53(4):603-25. PubMed ID: 10557579
    [No Abstract]   [Full Text] [Related]  

  • 19. Pushing drugs to doctors.
    Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(74):18869-82. PubMed ID: 12701600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.